When can warfarin be safely restarted in a patient with heparin‑induced thrombocytopenia (HIT)?

When to Safely Restart Warfarin in HIT

Warfarin should not be started until the platelet count has substantially recovered to at least 150 × 10⁹/L, and only after the patient has been therapeutically anticoagulated with a non-heparin anticoagulant for a minimum of 5 days with the INR in therapeutic range for 2 consecutive days. 1, 2

Critical Safety Requirements Before Starting Warfarin

Platelet Count Recovery

• Wait for platelets ≥150 × 10⁹/L before initiating warfarin 1, 2
• This threshold prevents venous limb gangrene, a catastrophic complication that can occur when warfarin is started during acute thrombocytopenia 2
• The 2018 ASH guidelines provide a strong recommendation (moderate certainty evidence) against starting warfarin before platelet recovery 1

Important caveat: One 2016 study 3 suggested that starting warfarin when platelets show an upward trend (rather than waiting for absolute recovery to 150 × 10⁹/L) may be safe and reduce hospital length of stay. However, this contradicts guideline recommendations and represents lower-quality evidence. In clinical practice, adhere to the guideline threshold of 150 × 10⁹/L to minimize risk of venous limb gangrene.

Therapeutic Anticoagulation Bridge

Before warfarin initiation, you must:

1. Discontinue all heparin products immediately (including flushes and heparin-coated catheters) 1, 2
2. Start a non-heparin anticoagulant at therapeutic doses 1, 2:
   • Argatroban
   • Bivalirudin
   • Danaparoid
   • Fondaparinux
   • Direct oral anticoagulants (DOACs)

Warfarin Initiation Protocol

Starting Warfarin

• Use low initial doses: Maximum 5 mg warfarin (or 6 mg phenprocoumon) 2
• Higher doses increase risk of warfarin-induced skin necrosis and venous limb gangrene 2

Overlap Period

• Continue the non-heparin anticoagulant for minimum 5 days after starting warfarin 2
• Do not stop the alternative anticoagulant until:
  • INR is therapeutic for 2 consecutive days 2, 4
  • Platelet count has normalized 5

Critical Monitoring Issue with Argatroban

If using argatroban, be aware that it artificially elevates the INR 2. Do not interpret the INR as therapeutic warfarin effect while argatroban is running. Twenty-one percent of patients with INR >3.0 on combined argatroban-warfarin had subtherapeutic INRs 4 hours after stopping argatroban 2. Consider switching to fondaparinux once platelets recover to simplify the transition to warfarin 2.

Special Circumstance: If Warfarin Already Started

If the patient is already taking warfarin when HIT is diagnosed 1, 2:

1. Stop warfarin immediately
2. Give intravenous vitamin K
3. Start therapeutic non-heparin anticoagulant
4. Restart warfarin only after platelet recovery using the protocol above

Duration of Anticoagulation

• HIT with thrombosis (HITT): Continue anticoagulation for 3 months (treating HIT as a reversible provoking factor for VTE) 2
• Isolated HIT: Continue until platelet count recovery, typically not beyond 3 months unless platelets remain low 1
• Some experts recommend at least 4 weeks of anticoagulation even for isolated HIT given the extended thrombotic risk 2

Common Pitfalls to Avoid

1. Starting warfarin too early (before platelet recovery) → venous limb gangrene
2. Using high initial warfarin doses → increased risk of skin necrosis
3. Stopping alternative anticoagulant too soon → recurrent thrombosis (7 of 16 new thromboses occurred the day after stopping argatroban prematurely) 2
4. Misinterpreting INR on argatroban → premature discontinuation of bridging anticoagulation
5. Simply stopping heparin without alternative anticoagulation → 30% risk of new thrombosis 2

The 2018 ASH guidelines now suggest DOACs over warfarin for subacute HIT (when acute phase has resolved), which avoids these complex transition issues entirely 1.